| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/12/2008 | US7410644 Recombinant pox virus for immunization against tumor-associated antigens |
| 08/12/2008 | US7410642 Assays and therapies for latent viral infection |
| 08/12/2008 | CA2547866C Farnesyl dibenzodiazepinone formulation |
| 08/12/2008 | CA2398111C 4-pyridyl-and 2,4-pyrimidinyl-substituted pyrrole derivatives and their use in pharmacy |
| 08/12/2008 | CA2376236C Modification of biological elements |
| 08/12/2008 | CA2350786C Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
| 08/12/2008 | CA2239799C Murine monoclonal anti-idiotype antibody 11d10 and methods of use thereof |
| 08/12/2008 | CA2217551C Photoactivated hypericin and the use thereof |
| 08/12/2008 | CA2188228C Use of isoxazole and crotonamide derivatives for the treatment of carcinomatous disorders |
| 08/12/2008 | CA2135787C Polypeptide bombesin antagonists |
| 08/07/2008 | WO2008094969A2 Combination therapy with angiogenesis inhibitors |
| 08/07/2008 | WO2008094942A2 Humanized antibodies against cxcr3 |
| 08/07/2008 | WO2008094896A1 N-substituted tricyclic 3-aminopyrazoles as anti-mitotic tubulin polymerization inhibitors |
| 08/07/2008 | WO2008094834A2 Multi-functional drug carriers |
| 08/07/2008 | WO2008094708A2 Activin-actriia antagonists and uses for treating or preventing breast cancer |
| 08/07/2008 | WO2008094602A2 1-h-pyrazolo (3,4b) pyrimidine derivatives and their use as modulators of mitotic kinases |
| 08/07/2008 | WO2008094575A2 1-h-pyrazolo(3,4b)pyrimidine derivatives and their use as modulators of mitotic kinases |
| 08/07/2008 | WO2008094574A2 Furanone compounds and methods of making and using the same |
| 08/07/2008 | WO2008094556A2 Imidazolone compounds as tgf-beta family type i receptors, alk5 and/or alk4 antagonists |
| 08/07/2008 | WO2008094484A2 Pharmaceutical compositions and methods of using temozolomide and multi-targeted kinase inhibitors |
| 08/07/2008 | WO2008094062A1 Pharmaceutical compositions useful for preventing and treating oncological diseases |
| 08/07/2008 | WO2008093855A1 Composition for treatment of undifferentiated-type of gastric cancer |
| 08/07/2008 | WO2008093853A1 Solid of macrolide compound, method for production thereof, and pharmaceutical composition comprising the same |
| 08/07/2008 | WO2008093838A1 Pyridyl imidazolidine derivative having sulfamoyl group, and pharmaceutical use thereof |
| 08/07/2008 | WO2008093825A1 Caffeine analog |
| 08/07/2008 | WO2008093700A1 Trehalose compound, process for production of the compound, and immuno-stimulative agent comprising the compound |
| 08/07/2008 | WO2008093677A1 Novel oxadiazole derivatives and thiadiazole derivatives having neovascularization inhibiting activity |
| 08/07/2008 | WO2008093674A1 Novel thiadiazole derivative having kinase inhibitory activity |
| 08/07/2008 | WO2008093646A1 Peptide capable of activating wnt signaling |
| 08/07/2008 | WO2008093464A1 Animal having modification in mgat2 gene |
| 08/07/2008 | WO2008093331A1 Antibody conjugates for circumventing multi-drug resistance |
| 08/07/2008 | WO2008093086A1 Modulators of hypoxia inducible factor-1 and related uses |
| 08/07/2008 | WO2008093075A2 5,6,7,8-tetrahydropteridine derivatives as hsp90 inhibitors |
| 08/07/2008 | WO2008093064A1 L-ALANINE DERIVATIVES AS α5 BETA 1 ANTAGONISTS |
| 08/07/2008 | WO2008092796A1 Antitumor combination comprising a morpholinyl anthracycline and an antibody |
| 08/07/2008 | WO2008092786A1 6-oxo-6,7-dihydro-5h-dibenzo[b,d]azepin-7-yl derivatives |
| 08/07/2008 | WO2008092352A1 Antitumor compounds and their preparation method |
| 08/07/2008 | WO2008092335A1 Novel vinblastine derivatives, their preparation, use and pharmaceutical compositions comprising the said derivatives |
| 08/07/2008 | WO2008092292A1 Isoquinolone compounds as subtype-selective agonists for melatonin receptors mt1 and mt2 |
| 08/07/2008 | WO2008092199A1 Thiopyrimidine-based compounds and uses thereof |
| 08/07/2008 | WO2008076960A3 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 08/07/2008 | WO2008076960A2 Antagonist anti-notch3 antibodies and their use in the prevention and treatment of notch3-related diseases |
| 08/07/2008 | WO2008067280A3 Combination of iap inhibitors and flt3 inhibitors |
| 08/07/2008 | WO2008064018A8 Thienopyrimidinones for treatment of inflammatory disorders and cancers |
| 08/07/2008 | WO2008061020A3 Methods of treating, diagnosing or detecting cancer |
| 08/07/2008 | WO2008057604A3 Small molecule therapeutics, syntheses of analogues and derivatives and methods of use |
| 08/07/2008 | WO2008054639A3 Use of a catechin or polyphenol to treat ocular diseases and infection |
| 08/07/2008 | WO2008053301A3 Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
| 08/07/2008 | WO2008053219B1 Composition for the treatment of gastrointestinal diseases |
| 08/07/2008 | WO2008051525A3 Methods of treating ovarian cancer |
| 08/07/2008 | WO2008039937A3 Blocking of gene expression in eukaryotic cells |
| 08/07/2008 | WO2008036642A3 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase |
| 08/07/2008 | WO2008034580A3 Uses of cripowellins and the derivatives thereof for the treatment of tumor diseases |
| 08/07/2008 | WO2008033449A3 Compounds for the treatment of angiogenesis |
| 08/07/2008 | WO2007140222A3 Pyrrolopyrimidine compounds and their uses |
| 08/07/2008 | WO2007124077A3 Immunoglobulin constant region domains with enhanced stability |
| 08/07/2008 | WO2007098118A3 Antineoplastic and curcumin derivatives and methods of preparation and use |
| 08/07/2008 | US20080188570 Therapeutic compounds |
| 08/07/2008 | US20080188559 Modified Retinoid Compounds and Their Uses |
| 08/07/2008 | US20080188557 Compounds with (substituted phenyl)-propenal moiety, their derivatives, biological activity, and use thereof |
| 08/07/2008 | US20080188544 Lyophilized formulations of salinosporamide a |
| 08/07/2008 | US20080188541 Combined with ascorbic acid, creatine and melatonin; inhibiting cancer and/or tumor cellular proliferation without toxic effect |
| 08/07/2008 | US20080188529 N1-(cyanomethyl)-N2-(2,2,2-trifluoro-1-phenylethyl)-L-leucinamide; antiarthritic agent; osteoporosis and other bone loss disorders |
| 08/07/2008 | US20080188527 Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer |
| 08/07/2008 | US20080188520 e.g. 1-(2-Cyclopropylmethoxy-1,2-diphenylethyl)-1H-pyridin-2-one; potassium (K+) channel-blocking agent; potassium channel KACh and TASK-1 channel blocking agent; atrial arrhythmias, atrial fibrillation or atrial flutter; respiratory disorders, neurodegenerative disorders; anticarcinogenic agent |
| 08/07/2008 | US20080188514 e.g. 5-(3-methoxybenzyloxy)-1H-pyrrolo[2,3-b]pyridine; protein kinases inhibitor; central nervous system disorders; Alzheimer's disease; Parkinson's disease; anticancer, antitumor agents; analgesics; cogestive heart failure; skin disorders; inflammatory bowel disorders; transplant rejection |
| 08/07/2008 | US20080188511 Rapamycin; the 40-hydroxy position is derivatised as a carboxylic acid ester, as an ether, as a phosphate ester, as a phosphinate ester, as an acetal or as a gycosyl; transplantation rejection, graft vs. host disease, autoimmune disorders, inflammation, vascular, fibrotic diseases |
| 08/07/2008 | US20080188501 retrovirus inhibor; anticarcinogenic, antidiabetic agent, immunosuppressant, autoimmune diseases; 2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-4-fluoro-benzonitrile; type 2 diabetes mellitus, impaired glucose tolerance, obesity, multiple sclerosis |
| 08/07/2008 | US20080188500 e.g. N-[4-methyl-3-(9H-pyrimido[4,5-b]indol-7-yl)phenyl]-3-(trifluoromethyl)benzamide; Janus kinases inhibitor; anticarcinogenic agent; immune-related diseases, skin disorders, myeloid proliferative disorders |
| 08/07/2008 | US20080188479 Methods to Treat Cancer with 10-propargyl-10-deazaaminopterin and Methods for Assessing Cancer for Increased Sensitivity to 10-propargyl-10-deazaaminopterin |
| 08/07/2008 | US20080188477 Substituted heterocycles, their use as medicament, and pharmaceutical preparations comprising them |
| 08/07/2008 | US20080188469 Vaccination |
| 08/07/2008 | US20080188460 Tricyclic compounds, a process for their preparation and pharmaceutical compositions containing them |
| 08/07/2008 | US20080188455 angiogenesis and/or cell proliferation, carcinoma, myeloid leukemia, endometriosis; inhibitors of the receptor protein tyrosine kinase; N3-(3-cyclopentyl-1,2,3,4,5,6-hexahydrobenzo[d]azocin-8-yl)-1-(6-fluoroquinazolin-4-yl)-1H-1,2,4-triazole-3,5-diamine |
| 08/07/2008 | US20080188454 angiogenesis and/or cell proliferation, carcinoma, myeloid leukemia, endometriosis; inhibitors of the receptor protein tyrosine kinase; N3-(3-cyclopentyl-1,2,3,4,5,6-hexahydrobenzo[d]azocin-8-yl)-1-(6-fluoroquinazolin-4-yl)-1H-1,2,4-triazole-3,5-diamine |
| 08/07/2008 | US20080188453 Mapk/erk kinase inhibitors |
| 08/07/2008 | US20080188452 Macrocyclic Benzofused Pyrimidine Derivatives |
| 08/07/2008 | US20080188451 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol1yl)-3-(trifluoromethyl)phenyl]benzamide or an N-oxide or salts; anticarcinogenic agent (leukaemia) |
| 08/07/2008 | US20080188450 Macrolactams by engineered biosynthesis |
| 08/07/2008 | US20080188448 reduced antiglucocorticoid effects; side effect reduction; endometriosis, leiomyomas of the uterus, dysfunctional bleeding, dysmenorrhoea; antitumor agents; female fertility control, for hormone replacement therapy; 6-[2(2,2-Dimethylpropyl)-2-hydroxypent-3-ynoylamino]-4-methyl-2,3-benzoxazin-1-one |
| 08/07/2008 | US20080188437 Compositions and Methods for siRNA Inhibition of Angiogenesis |
| 08/07/2008 | US20080188432 Short nucleotide subsequences located within number 15; such as locked nucleic acids antisense oligonucleotides; biostability, cell permeability; anticancer agents |
| 08/07/2008 | US20080188423 Pi-3 kinase inhibitor prodrugs |
| 08/07/2008 | US20080188421 Hunter-Killer Peptides and Methods of Use |
| 08/07/2008 | US20080188420 Daily intravenous administration of VEGFR1R2-Fc Delta C1 or coadministration with a cytotoxic, chemotherapeutic or antigrowth agent, while gradually decreasing dosage of the antagonist; colorectal cancer |
| 08/07/2008 | US20080188419 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 08/07/2008 | US20080188418 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 08/07/2008 | US20080188417 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 08/07/2008 | US20080188413 Polypeptides and/or polynucleotides selective for alpha v beta 3 integrin; osteoporosis, bone tumor or cancer growth, angiogenesis, Paget's disease, rheumatic arthritis, osteoarthritis; culture biosynthesis and chromatographic separation |
| 08/07/2008 | US20080188402 Novel heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 08/07/2008 | US20080188401 Compounds |
| 08/07/2008 | US20080188399 Drug-Polymer Conjugates Coupled to a Peptidic Carrier |
| 08/07/2008 | US20080187961 Polynucleotides encoding signal peptide-containing molecules |
| 08/07/2008 | US20080187608 Blocking nuclear factor kappa beta, oxidation stresses and endothelins receptors |
| 08/07/2008 | US20080187595 Method For Carrying Therapeutic Substances Into Cells |
| 08/07/2008 | US20080187575 Pyrimidine Derivatives |
| 08/07/2008 | US20080187552 Novel vaccine composition and use of surfactants as adjuvants of immunity |
| 08/07/2008 | US20080187551 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 08/07/2008 | US20080187550 Using bacterial dnaJ chaperone protein sequences as agent to enhance immune respone; for use in treatment and prevention of arthritic inflammation |
| 08/07/2008 | US20080187548 Ny-Eso-1 Peptides Which Bind To Class II Molecules And Uses Thereof |